The effect of pravastatin on intima media thickness of the carotid artery in patients with normal cholesterol

European Journal of Vascular and Endovascular Surgery

Volumn 30, Issue 5, 2005, Pages 464-468

  Reid, Julie Ann ^a,b   Wolsley, C ^b   Lau, L L ^a   Hannon, R J ^a   Lee, B ^a   Young, I S ^c   Soong, C V ^a  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Carotid artery; Intima media thickness; Normal cholesterol

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; PRAVASTATIN;

AGED; ARTERY DIAMETER; ARTERY MEDIA; ARTERY WALL; ARTICLE; BLOOD ANALYSIS; CAROTID ARTERIOGRAPHY; CAROTID ARTERY OBSTRUCTION; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COMMON CAROTID ARTERY; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TREATMENT PLANNING; WILCOXON SIGNED RANKS TEST;

AGED; CAROTID ARTERY, COMMON; CAROTID STENOSIS; CHOLESTEROL; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; PRAVASTATIN; TUNICA INTIMA; TUNICA MEDIA;

EID: 26944436268     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2005.05.007     Document Type: Article

References (32)

1. A. Simon J.L. Megnien J. Levenson Coronary risk estimation and treatment of hypercholesterolemia Circulation 96 7 1997 2449-2452
2. S.C. Smith Jr P. Greenland S.M. Grundy AHA conference proceedings. Prevention conference VI Beyond secondary prevention: identifying the high-risk patient for primary prevention: Executive summary. American Heart Association Circulation 101 1 2000 111-116
3. A. Aminbakhsh G.B. Mancini Carotid intima-media thickness measurements: what defines an abnormality? A systematic review Clin Invest Med 22 4 1999 149-157
4. J. Gariepy J. Salomon N. Denarie F. Laskri J.L. Megnien J. Levenson et al. Sex and topographic differences in associations between large-artery wall thickness and coronary risk profile in a French working cohort: The AXA study Arterioscler Thromb Vasc Biol 18 4 1998 584-590
5. A. Zanchetti G. Crepaldi M.G. Bond G.V. Gallus F. Veglia A. Ventura et al. Systolic and pulse blood pressures (but not diastolic blood pressure and serum cholesterol) are associated with alterations in carotid intima-media thickness in the moderately hypercholesterolaemic hypertensive patients of the Plaque Hypertension Lipid Lowering Italian Study. PHYLLIS study group J Hypertens 19 1 2001 79-88
6. A. Zanchetti M.G. Bond M. Hennig A. Neiss G. Mancia C. Dal Palu et al Risk factors associated with alterations in carotid intima-media thickness in hypertension: Baseline data from the European Lacidipine Study on Atherosclerosis J Hypertens 16 7 1998 949-961
7. A. Poli E. Tremoli A. Colombo M. Sirtori P. Pignoli R. Paoletti Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients. A new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects Atherosclerosis 70 3 1988 253-261
8. J. Gariepy A. Simon M. Massonneau A. Linhart J. Levenson Wall thickening of carotid and femoral arteries in male subjects with isolated hypercholesterolemia. PCVMETRA Group. Prevention Cardio-Vasculaire en Medecine du Travail Atherosclerosis 113 2 1995 141-151
9. L. Mykkanen D.J. Zaccaro D.H. O'Leary G. Howard D.C. Robbins S.M. Haffner Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The Insulin Resistance Atherosclerosis Study (IRAS) Stroke 28 9 1997 1710-1716
10. M. Hanefeld C. Koehler F. Schaper K. Fuecker E. Henkel T. Temelkova-Kurktschiev Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals Atherosclerosis 144 1 1999 229-235
11. G. Bolinder A. Noren U. de Faire J. Wahren Smokeless tobacco use and atherosclerosis: An ultrasonographic investigation of carotid intima media thickness in healthy middle-aged men Atherosclerosis 132 1 1997 95-103
12. J. Persson J. Formgren B. Israelsson G. Berglund Ultrasound-determined intima-media thickness and atherosclerosis. Direct and indirect validation Arterioscler Thromb 14 2 1994 261-264
13. J.T. Salonen R. Salonen Ultrasonographically assessed carotid morphology and the risk of coronary heart disease Arterioscler Thromb 11 5 1991 1245-1249
14. L.E. Chambless G. Heiss A.R. Folsom W. Rosamond M. Szklo A.R. Sharrett Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993 Am J Epidemiol 146 6 1997 483-494
15. L.E. Chambless A.R. Folsom L.X. Clegg A.R. Sharrett E. Shahar F.J. Nieto et al. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) Study Am J Epidemiol 151 5 2000 478-487
16. D.H. O'Leary J.F. Polak R.A. Kronmal T.A. Manolio G.L. Burke S.K. Wolfson Jr Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group N Engl J Med 340 1 1999 14-22
17. M.L. Bots A.W. Hoes P.J. Koudstaal A. Hofman D.E. Grobbee Common carotid intima-media thickness and risk of stroke and myocardial infarction: The Rotterdam Study Circulation 96 5 1997 1432-1437
18. H.N. Hodis W.J. Mack L. LaBree R.H. Selzer C.R. Liu C.H. Liu et al The role of carotid arterial intima-media thickness in predicting clinical coronary events Ann Intern Med 128 4 1998 262-269
19. C.D. Furberg H.P. Adams Jr W.B. Applegate R.P. Byington M.A. Espeland T. Hartwell et al Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group Circulation 90 4 1994 1679-1687
20. R. Salonen K. Nyssonen E. Porkkala-Sarataho J.T. Salonen The Kuopio Atherosclerosis Prevention Study (KAPS): Effect of pravastatin treatment on lipids, oxidation resistance of lipoproteins, and atherosclerotic progression Am J Cardiol 76 9 1995 34C-39C
21. E. de Groot J.W. Jukema A.D. Montauban van Swijndregt A.H. Zwinderman R.G. Ackerstaff A.F. van der Steen et al. B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: A report of the Regression Growth Evaluation Statin Study (REGRESS) J Am Coll Cardiol 31 7 1998 1561-1567
22. H.N. Hodis W.J. Mack L. LaBree R.H. Selzer C. Liu P. Alaupovic et al Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: A randomized controlled clinical trial Ann Intern Med 124 6 1996 548-556
23. S. MacMahon N. Sharpe G. Gamble H. Hart J. Scott J. Simes et al. Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: Results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group Circulation 97 18 1998 1784-1790
24. D. Labarthe Epidemiology and prevention of cardiovascular diseases: A global challenge 1998 Aspen Publishing Gaithersberg
25. G.L. Burke G.W. Evans W.A. Riley A.R. Sharrett G. Howard R.W. Barnes et al. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study Stroke 26 3 1995 386-391
26. T.J. Smilde S. van Wissen H. Wollersheim M.D. Trip J.J. Kastelein A.F. Stalenhoef Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): A prospective, randomised, double-blind trial Lancet 357 9256 2001 577-581
27. A.J. Taylor S.M. Kent P.J. Flaherty L.C. Coyle T.T. Markwood M.N. Vernalis ARBITER: Arterial biology for the investigation of the treatment effects of reducing cholesterol: A randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness Circulation 106 16 2002 2055-2060
28. S. Keidar M. Aviram I. Maor J. Oiknine J.G. Brook Pravastatin inhibits cellular cholesterol synthesis and increases low density lipoprotein receptor activity in macrophages: In vitro and in vivo studies Br J Clin Pharmacol 38 6 1994 513-519
29. K. Egashira Y. Hirooka H. Kai M. Sugimachi S. Suzuki T. Inou et al Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia Circulation 89 6 1994 2519-2524
30. G. O'Driscoll D. Green R.R. Taylor Simvastatin, an HMG-coenzyme a reductase inhibitor, improves endothelial function within 1 month Circulation 95 5 1997 1126-1131
31. L. Lacoste J.Y. Lam J. Hung G. Letchacovski C.B. Solymoss D. Waters Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction Circulation 92 11 1995 3172-3177
32. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet 2002;360(9326):7-22.